Dublin, Dec. 05, 2025 (GLOBE NEWSWIRE) -- The "Bioburden Testing Market - Forecasts from 2025 to 2030" report has been added to ResearchAndMarkets.com's offering. The Bioburden Testing Market is ...

The Global Bioburden Testing Market has experienced consistent growth, with a compound annual growth rate (CAGR) of 12-15%. This growth is driven by tightening regulatory standards and an increasing ...

According to Nova One Advisor, the global pharmaceutical rapid microbiology testing market size is calculated at 1.25 billion in 2024 and is projected to surpass USD 6.29 billion by 2034 with a ...

Since 2010, Juliana has been a professional writer in the technology and small business worlds. She has both journalism and copywriting experience and is exceptional at distilling complex concepts ...

As biopharma companies fine-tune their strategies for continuous bioprocessing, bioburden control has become a top priority. The approaches that worked for batch processing are inadequate for ...

Another driver contributing to the market growth is the growing emphasis on regulatory compliance. Regulatory authorities across the globe are imposing strict guidelines and regulations regarding ...

As a supply chain organisation, Meds supplies pharmaceutical medicines to the health facilities in Kenya and beyond.However, the organisation has not been in a position to check for microbial ...

Webinar Date/Time: Wed, Nov 15, 2023 11:00 AM EST 3:00 PM GMT | 4:00 PM BST Maximizing efficiency and controlling contamination are necessary in microbiology applications. Dedicated microbiology ...